This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd.. Active years: 2026.
Company Filing History:
2 out of 3 
2 out of 3 Years Active: 2026
Title: Innovations and Contributions of Inventor Xiaoyong Shi
Introduction
Xiaoyong Shi is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, his work focuses on compounds with therapeutic potential.
Latest Patents
Xiaoyong Shi's latest patents include a triazinylmethylcycloalkylcarboxylic acid derivative and a pharmaceutical composition that utilizes this derivative. The compound exhibits significant P2X3 inhibitory activity and selectivity, highlighting its high application value in medical treatments. Additionally, he has developed substituted oxaspiro[4.5]decanes as morphine receptor agonists, providing new avenues for pain management and therapeutic applications.
Career Highlights
Throughout his career, Xiaoyong Shi has worked with prominent companies in the pharmaceutical industry. He has been associated with Yangtze River Pharmaceutical Group Co., Ltd. and Shanghai Haiyan Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Xiaoyong Shi has collaborated with notable professionals in his field, including Bin Hu and Jing Xie. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.
Conclusion
Xiaoyong Shi's contributions to pharmaceutical innovation are noteworthy, with his patents reflecting significant advancements in therapeutic compounds. His work continues to impact the field positively, showcasing the importance of innovation in medicine.